Latest News for: traver

Edit

Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027

The Daily Record - Dunn 17 Jun 2026
William Rote, Ph.D., chief research officer plans to retire in early 2027 Jula Inrig, M.D., to be named executive vice ....
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Travere Therapeutics Inc)

Public Technologies 17 Jun 2026
) ... Registration No. 333- ... 20549 ... TRAVERE THERAPEUTICS, INC ... Travere Therapeutics, Inc ... Travere Therapeutics, Inc ... Travere Therapeutics, Inc ... □ ... 2 ... 99.1 Travere Therapeutics, Inc ... 99.4 Travere Therapeutics, Inc ... TRAVERE THERAPEUTICS, INC ... Travere Therapeutics Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Travere Therapeutics Inc)

Public Technologies 16 Jun 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... Travere Therapeutics, Inc ... C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DR., SUITE 300 3 ... C/O TRAVERE THERAPEUTICS, INC ... Travere Therapeutics Inc.
Edit

Current Report (Form 8-K) (Travere Therapeutics Inc)

Public Technologies 16 Jun 2026
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. ___________________________. FORM 8-K. ___________________________. Current Report ... June 12, 2026 ... TRAVERE THERAPEUTICS, INC ... ¨ ... TRAVERE THERAPEUTICS, INC ... Travere Therapeutics Inc.
Edit

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Norfolk Daily News 12 Jun 2026
Travere Therapeutics, Inc. (Nasdaq. TVTX) today announced that on June 10, 2026, the Compensation Committee of its ... .
Edit

Notice of Proposed Sale of Securities (Form 144) (Travere Therapeutics Inc)

Public Technologies 12 Jun 2026
). The text version of this document is not available ... Travere Therapeutics Inc.
Edit

Boom Boom: Pat Travers to put out the lights in Hobart

The Indiana Times 11 Jun 2026
Rock and blues guitar legend Pat Travers will perform Friday at Hobart Art Theater, with a free pre-show meet-and-greet at The Record Bin ... .
Edit

HORSE RACING: G2 Jim Dandy, Travers possible for Renegade; allowance likely next spot for Powershift

The Oneida Daily Dispatch 09 Jun 2026
SARATOGA SPRINGS, N.Y.
Edit

Golden Tempo Headed to Jim Dandy, Travers at Saratoga

Bloodhorse 07 Jun 2026
The year may be halfway over, but Golden Tempo seems a lot more than halfway to being crowned the champion 3-year-old male ... .
Edit

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class ...

Antara News 05 Jun 2026
Hong Kong (ANTARA/ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration agreement with Travere Therapeutics, Inc ... Travere will ...
Edit

Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the ...

Enid News & Eagle 04 Jun 2026
SAN DIEGO--(BUSINESS WIRE)--Jun 4, 2026-- ... .
Edit

Travere Therapeutics Enters Into Exclusive Licensing Agreement with Everest Medicines for Civorebrutinib a Potential Best-in-Class ...

Rutland Herald 02 Jun 2026
SAN DIEGO--(BUSINESS WIRE)--Jun 2, 2026-- ....
Edit

Material Agreement (Form 8-K) (Travere Therapeutics Inc)

Public Technologies 02 Jun 2026
). Item 1.01 Entry into a Material Definitive Agreement. On June 1, 2026, Travere Therapeutics, Inc ... Ltd ... Everest is obligated to make such payment following its receipt of the upfront payment from the Company described below ... Travere Therapeutics Inc.
Edit

Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. ...

Business Wire 28 May 2026
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq ... Patent Application No.
Edit

Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in IgA Nephropathy (Travere Therapeutics Inc)

Public Technologies 27 May 2026
SAN DIEGO--(BUSINESS WIRE)-- Travere Therapeutics, Inc ... About Travere Therapeutics. At Travere Therapeutics, we are in rare for life ... For more information, visit travere.com ... 888-969-7879 ir@travere.com ... 888-969-7879 mediarelations@travere.com.

Article Search

tools
×
×
×
×